Profund Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57M | Sell |
5,190
-1,063
| -17% | -$322K | 0.06% | 221 |
|
|
2025
Q1 | $2.07M | Sell |
6,253
-231
| -4% | -$76.5K | 0.09% | 171 |
|
|
2024
Q4 | $2M | Sell |
6,484
-2,323
| -26% | -$717K | 0.07% | 184 |
|
|
2024
Q3 | $1.87M | Buy |
8,807
+1,991
| +29% | +$423K | 0.07% | 198 |
|
|
2024
Q2 | $1.91M | Buy |
6,816
+1,053
| +18% | +$295K | 0.07% | 185 |
|
|
2024
Q1 | $1.54M | Sell |
5,763
-1,397
| -20% | -$373K | 0.06% | 220 |
|
|
2023
Q4 | $1.66M | Sell |
7,160
-563
| -7% | -$130K | 0.07% | 212 |
|
|
2023
Q3 | $1.13M | Buy |
7,723
+1,898
| +33% | +$277K | 0.06% | 261 |
|
|
2023
Q2 | $1.35M | Buy |
5,825
+459
| +9% | +$106K | 0.07% | 244 |
|
|
2023
Q1 | $1.3M | Buy |
5,366
+4,233
| +374% | +$1.03M | 0.08% | 227 |
|
|
2022
Q4 | $329K | Buy |
+1,133
| New | +$329K | 0.02% | 592 |
|
|
2019
Q1 | – | Sell |
-1,829
| Closed | -$206K | – | 1225 |
|
|
2018
Q4 | $206K | Buy |
1,829
+67
| +4% | +$7.55K | 0.01% | 1014 |
|
|
2018
Q3 | $377K | Buy |
+1,762
| New | +$377K | 0.01% | 1026 |
|